These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8340203)

  • 1. Health technologies for the developing world. Promoting self-reliance through improving local procurement and manufacturing capabilities.
    Free MJ; Green JA; Morrow MM
    Int J Technol Assess Health Care; 1993; 9(3):380-96. PubMed ID: 8340203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technological and social innovation: a unifying new paradigm for global health.
    Gardner CA; Acharya T; Yach D
    Health Aff (Millwood); 2007; 26(4):1052-61. PubMed ID: 17630448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Science and technology for wealth and health in developing countries.
    Acharya T
    Glob Public Health; 2007; 2(1):53-63. PubMed ID: 19280387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Private sector joins family planning effort.
    Front Lines; 1989 Dec; ():6, 13. PubMed ID: 12343476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The global capacity for manufacturing vaccines. Prospects for competition and collaboration among producers in the next decade.
    Robbins A; Arita I
    Int J Technol Assess Health Care; 1994; 10(1):39-46. PubMed ID: 8157459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health innovation networks to help developing countries address neglected diseases.
    Morel CM; Acharya T; Broun D; Dangi A; Elias C; Ganguly NK; Gardner CA; Gupta RK; Haycock J; Heher AD; Hotez PJ; Kettler HE; Keusch GT; Krattiger AF; Kreutz FT; Lall S; Lee K; Mahoney R; Martinez-Palomo A; Mashelkar RA; Matlin SA; Mzimba M; Oehler J; Ridley RG; Senanayake P; Singer P; Yun M
    Science; 2005 Jul; 309(5733):401-4. PubMed ID: 16020723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The strategic approach to contraceptive introduction.
    Simmons R; Hall P; Díaz J; Díaz M; Fajans P; Satia J
    Stud Fam Plann; 1997 Jun; 28(2):79-94. PubMed ID: 9216029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal health development programs: comparing priorities of bilateral and private donors.
    Deleye C; Lang A
    BMC Int Health Hum Rights; 2014 Nov; 14():31. PubMed ID: 25406685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An analysis of the pharmaceuticals market in Vietnam].
    Simonet D
    Sante; 2001; 11(3):155-60. PubMed ID: 11641078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decentralization and primary health care: some negative implications in developing countries.
    Collins C; Green A
    Int J Health Serv; 1994; 24(3):459-75. PubMed ID: 7928013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Public and private donor financing for health in developing countries.
    Howard LM
    Infect Dis Clin North Am; 1991 Jun; 5(2):221-34. PubMed ID: 1869807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to Achieve Transparency in Public-Private Partnerships Engaged in Hunger and Malnutrition Reduction.
    Eggersdorfer M; Bird JK
    World Rev Nutr Diet; 2016; 115():224-32. PubMed ID: 27198563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technology assessment and transfer in district health systems.
    Tjam FS
    World Hosp Health Serv; 1994; 30(2):3-8. PubMed ID: 10142971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Children's Vaccine Initiative and vaccine supply: the role of the public sector.
    van Noort RB
    Vaccine; 1992; 10(13):909-10. PubMed ID: 1471410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drugs for STD management in developing countries: choice, procurement, cost, and financing.
    Van der Veen F; Fransen L
    Sex Transm Infect; 1998 Jun; 74 Suppl 1():S166-74. PubMed ID: 10023369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When do developing countries adopt managed care policies and technologies? Part I: Policies, experience, and a framework of preconditions.
    Peabody JW; Luck J
    Am J Manag Care; 2002 Nov; 8(11):997-1007. PubMed ID: 12437314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug utilization studies: their transferability between industrialized and developing countries.
    Lee D; Balasubramaniam K; Ali HM
    WHO Reg Publ Eur Ser; 1993; 45():193-218. PubMed ID: 8442847
    [No Abstract]   [Full Text] [Related]  

  • 18. Crowd-sourcing delivery system innovation: A public-private solution.
    Agrawal S; Chen C; Tanio CP
    Healthc (Amst); 2015 Mar; 3(1):2-4. PubMed ID: 26179583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost containment through pharmaceutical procurement: a Caribbean case study.
    Huff-Rousselle M; Burnett F
    Int J Health Plann Manage; 1996; 11(2):135-57. PubMed ID: 10172681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The uses of modern technologies: problems and perspectives for industrialized and developing countries.
    Banta D
    Bull Pan Am Health Organ; 1984; 18(2):139-50. PubMed ID: 6487871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.